| Name | Reozalimab |
|---|---|
| Synonyms |
ade Reozalimab
ade Reozalimab (DHJ70121) |
| Description | Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |